Udhayvir Grewal (@UGrewalMD)

Pinned

U

Excited to share that I will be joining @WinshipAtEmory (Atlanta, GA) as a GI/NET Medical Oncologist. I feel fortunate to finally have the opportunity to live the dream of caring for patients with GI and neuroendocrine cancers. Grateful to mentors and colleagues @UIowaCancer for…

UGrewalMD's tweet image. Excited to share that I will be joining @WinshipAtEmory (Atlanta, GA) as a GI/NET Medical Oncologist. I feel fortunate to finally have the opportunity to live the dream of caring for patients with GI and neuroendocrine cancers. Grateful to mentors and colleagues @UIowaCancer for…

32

14

186

2

12.0K

U

Udhayvir Grewal@UGrewalMD · Jul 26

It was great talking to my colleagues from Nevada and around about updates in upper GI cancers #ASCODirectLV Thank you @TotalHealthConf for the opportunity. @TheGutOncLab

UGrewalMD's tweet image. It was great talking to my colleagues from Nevada and around about updates in upper GI cancers #ASCODirectLV
Thank you @TotalHealthConf for the opportunity. @TheGutOncLab

0

2

14

0

534

Udhayvir Grewal Retweeted

W

Winship Cancer Institute of Emory University@WinshipAtEmory · Jul 26

Winship neuroendocrine medical oncologist Daniel M. Halperin, MD highlights key takeaways from his presentation during the GI cancers session at #DDHO2025. 🧬

0

1

5

0

308

U

Udhayvir Grewal@UGrewalMD · Jul 25

Great job by these bright future oncologists.

GGut Onc Lab@TheGutOncLab · Jul 25

Excited to share that @sidmahajan11 (@MacNealHosp) @SuriyaBaskarMD @official_tbhc) & Matt Gao (@IowaMed) had abstracts accepted for poster presentation at @ASCO Qlty Care Symp #ASCOQLTY25 @TimothyJBrownMD @UGrewalMD @GIMedOnc @Deebacca @sawyer_bawek @BRoseMDMPH Phenomenal work 👏

0

2

9

0

560

U

Udhayvir Grewal@UGrewalMD · Jul 25

Phenomenal work indeed. I’m fortunate to have the opportunity to work with and mentor these amazingly talented folks. 💯

GGut Onc Lab@TheGutOncLab · Jul 25

Excited to share that @sidmahajan11 (@MacNealHosp) @SuriyaBaskarMD @official_tbhc) & Matt Gao (@IowaMed) had abstracts accepted for poster presentation at @ASCO Qlty Care Symp #ASCOQLTY25 @TimothyJBrownMD @UGrewalMD @GIMedOnc @Deebacca @sawyer_bawek @BRoseMDMPH Phenomenal work 👏

0

2

11

0

677

U

Udhayvir Grewal@UGrewalMD · Jul 25

En route Las Vegas ☀️ 🏙️🏜️ for a talk on @ASCO 2025 updates in Upper GI Cancers at the Total Health ASCO Direct. @WinshipAtEmory

0

2

16

0

771

U

Udhayvir Grewal@UGrewalMD · Jul 24

🔥I’m excited to share that I’ll be speaking at the upcoming @NANETS1 Regional NET Education Conference in Birmingham, AL, on Saturday, September 13, 2025. ⭐️ This one-day event brings together experts from across the Southeast 🇺🇸 for an in-depth, multidisciplinary program…

UGrewalMD's tweet image. 🔥I’m excited to share that I’ll be speaking at the upcoming @NANETS1 Regional NET Education Conference in Birmingham, AL, on Saturday, September 13, 2025.

⭐️ This one-day event brings together experts from across the Southeast 🇺🇸 for an in-depth, multidisciplinary program…

0

1

20

0

713

Udhayvir Grewal Retweeted

T

Tim Brown, MD MSCE@TimothyJBrownMD · Jul 24

Full conference room this morning @UTSWHemeOnc academic half day to listen to @SyedKazmiMD discuss reviewing the literature and understanding study design

0

1

8

0

415

Udhayvir Grewal Retweeted

N

Nicholas Hornstein@GIMedOnc · Jul 24

As we’ve launched a new HAI program in Manhattan at Northwell, questions around optimal dosing strategies are front and center. This new @cityofhope study asks: can we de-escalate initial FUDR dosing and still preserve outcomes in adjuvant HAI? Retrospective and single-center —…

0

4

16

1

1.0K

U

Udhayvir Grewal@UGrewalMD · Jul 24

Are you, like me, starting to get overwhelmed with the wealth of options in upper GI? HER2 PDL1 MSI-H CLDN18.2 (Now FGFR2) Well, @UGrewalMD and @TimothyJBrownMD have a great review article piecing it all together. Next goal... Get one person on tumor board to stop recommending…

UUdhayvir Grewal@UGrewalMD · Jul 24

Checkout this piece where @TimothyJBrownMD and I try to take on the challenging task of describing zolbetuximab’s place in the advanced GEC treatment paradigm. @TheGutOncLab @GIMedOnc @Deebacca P.S. we are already thinking about how we’re going to update this algorithm to…

0

5

19

1

1.0K

U

Udhayvir Grewal@UGrewalMD · Jul 24

Checkout this piece where @TimothyJBrownMD and I try to take on the challenging task of describing zolbetuximab’s place in the advanced GEC treatment paradigm. @TheGutOncLab @GIMedOnc @Deebacca P.S. we are already thinking about how we’re going to update this algorithm to…

TThe Oncologist@OncJournal · Jul 24

Drs @UGrewalMD and @TimothyJBrownMD discuss the evolving treatment of #stmcsm with new targeted agents 🎯like zolbetuximab for #HER2- but #CLDN182+ disease. They describe 4 biomarker (MSI/MMR, HER2, PD-L1, CLDN18.2) profiles that guide therapy #GIonc doi.org/10.1093/oncolo…

0

6

24

2

3.0K

Udhayvir Grewal Retweeted

R

Rachel Riechelmann@RachelRiechelm2 · Jul 23

❗️MUTYH mutant #pancreatic #NET (germline/somatic) ✅3% ✅50% second hit genetic event ✅2/3 G1/2 evolved to G3 ✅3/7 tumors molecularly profiled after alkylating drugs and/or PRRT had high TMB ✅ aggressive , high-grade disease when metastatic @TAMedOncol @gitorrezan

5

24

54

15

3.0K

Udhayvir Grewal Retweeted

N

Nicholas Hornstein@GIMedOnc · Jul 23

💥New paper out! We reanalyzed raw sequencing data from 18,558 standard-of-care Guardant360 ctDNA assays in advanced #colorectalcancer using a partner-agnostic fusion caller. 🧬 Fusions in 1.3% of patients 🧪 93% were subclonal — enriched after EGFR therapy 🔗 Clonal fusions…

1

15

31

6

3.0K

Udhayvir Grewal Retweeted

N

Nicholas Hornstein@GIMedOnc · Jul 23

Another new paper out! Grateful to have been a part of the effort. We (Andrew Pellatt and Arvind Dasari) asked: Can TAS-102 eliminate ctDNA-defined MRD in CRC after adjuvant chemo? 💊 Single-arm phase II study of CRC pts with MRD by ctDNA after curative-intent therapy (Stage…

2

11

36

5

3.0K

U

Udhayvir Grewal@UGrewalMD · Jul 23

Here’s to new beginnings. Excited for the new chapter and all the wonderful things that are yet to happen. @WinshipAtEmory

19

6

141

0

6.0K

U

Udhayvir Grewal@UGrewalMD · Jul 22

So much good science! Gut Onc Lab should be well represented at GI-ASCO. Really excited for some of the things we’re working on as they’re progressing from concept, to data and now publication.

GGut Onc Lab@TheGutOncLab · Jul 22

We are growing!!! Love our biweekly lab meetings and all the cool ideas/collaborations. We are also trying to match @Deebacca’s background game; guess we will get there one day. Watch this space for more 🚀 🔥 @TimothyJBrownMD @GIMedOnc @UGrewalMD @BRoseMDMPH @sawyer_bawek

2

3

17

0

2.0K

U

Udhayvir Grewal@UGrewalMD · Jul 22

Love these people and love to see that the lab is growing. Couldn’t have asked for a better team.

GGut Onc Lab@TheGutOncLab · Jul 22

We are growing!!! Love our biweekly lab meetings and all the cool ideas/collaborations. We are also trying to match @Deebacca’s background game; guess we will get there one day. Watch this space for more 🚀 🔥 @TimothyJBrownMD @GIMedOnc @UGrewalMD @BRoseMDMPH @sawyer_bawek

0

7

0

486

U

Udhayvir Grewal@UGrewalMD · Jul 21

💯 % agree “discontinuing trials for which participants have already volunteered and are undergoing treatment does an enormous disservice to patients.”

EECOG-ACRIN Cancer Research Group@eaonc · Jul 21

Read more from our co-chairs on the importance of protecting public support for biomedical research: bit.ly/3IvxNQD #CancerResearch #ClinicalTrials

0

6

15

0

1.0K

U

Udhayvir Grewal@UGrewalMD · Jul 21

🔥 Save the date! Excited for our upcoming @NANETS1 Regional in Birmingham AL. Looking forward to my first NET talk as faculty and interacting with friends, colleagues and patients from all over. @WinshipAtEmory @UABHeersink 🦓🎗️

NNANETS@NANETS1 · Jul 21

Mark your calendars for the Birmingham, AL NET Regional Conference! Details here: nanets.net/education/regi… #NETCare #MedicalEducation #NETRegional #NANETS

0

7

0

437

U

Udhayvir Grewal@UGrewalMD · Jul 20

Excellent study just out in ESMO GI Onc- 📊 Among 15 CLDN18.2⁺ gastric cancer pts treated w/ zolbetuximab: 🔹 53.3% lost CLDN18.2 ≥75% at progression 🔹 66.7% retained ≥40% 🔹 73.3% retained ≥25% 💡 Patients may still be eligible for next-gen CLDN18.2-targeted therapies…

UGrewalMD's tweet image. Excellent study just out in ESMO GI Onc-

📊 Among 15 CLDN18.2⁺ gastric cancer pts treated w/ zolbetuximab:

🔹 53.3% lost CLDN18.2 ≥75% at progression
🔹 66.7% retained ≥40%
🔹 73.3% retained ≥25%

💡 Patients may still be eligible for next-gen CLDN18.2-targeted therapies…

1

9

30

7

2.0K

Udhayvir Grewal Retweeted

R

Roswell Park@RoswellPark · Jul 18

We're proud to celebrate Dr. Vadehra, honored with a teaching award by the Surgical Oncology Fellow Class of 2025! 👏 “Thank you to the fellows for the opportunity to help teach you, and I know you will all do great things to help the patients who need you.”

1

3

21

0

821